This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
Hope for cancer cell “anchors”
Antibodies in cancer breakthrough
Swine-flu vaccine stocks readied
Research rejects smoking drug risks
UCB announce convertible bond offering increase
UCB successfully completes its convertible bond offering
Automating the preparation of chemotherapy in a UK Pharmacy department
Managing breakthrough pain in cancer – current and emerging
Bayer results require further analysis and interpretation
UCB launches an offer of up to €350 million convertible bonds
Named patient treatment between benefit and hazard
UCB and AstraZeneca form alliance for the commercialisation of Cimzia in Brazil
« Previous
1
…
109
110
111
112
113
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: